The company is developing a drug to treat traumatic brain injury using a molecule extracted from marine macroalgae. This molecule targets the immune system to promote repair after brain trauma. The therapy aims to reduce stimulate the immune cells and enhance neurological recovery. We also work to valorise extraction by-products, ensuring a sustainable, biotech-driven approach to neurorepair. Expertise is sought in polysaccharide chemistry and extraction of molecules at pharmaceutical grade.
Ref. BRDE20260701021 Fabricante alemán de ingredientes para repostería y productos de postre busca socios internacionales para la fabricación por contrato de productos de marca blanca y de marca propia.
A German manufacturer of baking ingredients, desserts, decorative baking products, gelatine products, thickening agents and baking mixes seeks experienced food manufacturers for the production of products under private-label and branded concepts. The company is...
Jul 28, 2026
















